Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Angiosarcoma. According to GlobalData, Phase I drugs for Angiosarcoma does not have sufficient ...

How tissue fluidity affects brain tumor development Huiyu Pharmaceutical's Paclitaxel Injection to be incl ...

INR:6196. india vs nz u19 world cup scorecard New approach promotes CAR-T cell survival and proliferation in solid tumors ...

INR:6298. fifa world cup final 2023 The first traditional Chinese medicine for the prevention and treatment of COVID-19 has received clinical approval N ...